Platelet-Rich Plasma Does Not Improve Pain or Cartilage Volume in Knee Osteoarthritis .
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial.
JAMA . 2021 Nov 23;326(20):2021-2030.Two hundred and eighty eight patients with mild to moderate knee osteoarthritis (OA) were randomized to receive 3 intra-articular injections of leukocyte-poor platelet-rich plasma (PRP, n=144) or a placebo injection (n=144). The primary outcomes of interest were subjective pain scores and percentage change in medial tibial cartilage volume. Secondary outcomes of interest evaluated pain, function, quality of life, global change and joint structures on imaging. There was no difference in the change in pain or change in medial tibial cartilage volume at 1 year follow-up. Of the 31 pre-specified secondary outcomes, there were no differences noted in 29 of them.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics